PCLAF and breast carcinoma: However, KIAA0101 (Figure 6(i)), PBK (Figure 6(j)), SPAG5 (Figure 6(k)), SPP1 (Figure 6(l)), DCN (Figure 6(m)), FZD7 (Figure 6(n)), KRT5 (Figure 6(o)), and TGFBR3 (Figure 6(p)) were scientifically downregulated in breast cancer compared to normal samples.